Navigation Links
‘Path to 2025’ Alzheimer’s Disease Summit: Reforms Urgently Needed to Streamline Road to Alzheimer’s Prevention and Treatment as Global Prevalence is Set to Triple
Date:11/6/2013

ent Currently Three Times Industry Average

One of the significant findings in the report is that the major bottlenecks in identifying an effective Alzheimer’s disease treatment are the high cost and risk of drug development and research, particularly large clinical trials of thousands of patients over multiple years that test a single drug. The report estimates that the total cost of bringing an effective Alzheimer’s treatment to market currently approaches $6 billion – nearly three times the industry average for drug development. (Total cost includes expenditures on an effective drug and on the failed drugs preceding it.)

The report considers the likely economic impacts of adopting a series of recommendations made by government agencies, expert panels, and other bodies to streamline how Alzheimer’s drugs are developed and tested. Among the reforms recommended are:

  • Developing reliable disease markers to predict the progression of Alzheimer’s disease in different patients and better match people with treatments likely to work for them;
  • Making clinical trials more efficient and less costly by establishing global trial-ready cohorts of eligible clinical trial participants as well as using adaptive trial designs that will enable the testing of multiple drugs, in combination, tailored for different at-risk populations;
  • Establishing data-sharing arrangements for companies to share precompetitive research results so that other scientists can learn more rapidly how to slow or stop Alzheimer’s; and
  • Promoting public-private partnerships that pool resources from governments, academia, industry, and patient advocates to co-invest in Alzheimer’s drug development and testing.

The report estimates that implementing these and other reforms to Alzheimer’s drug development would reduce the total cost of developing an effective Alzheimer’s treatment by nearly
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. The Alzheimer’s Caregiver™ Offers a New Educational Concept of Care That Bridges the Gap between Research and Caregiving
2. The Alzheimer’s Caregiver™ - Bridges the Gap between Research and Care
3. National League for Nursing to Create Alzheimer’s Curricula and Resources for Nurse Educators
4. Physicians Group Calls on the FDA to Repurpose Enbrel for the Treatment of TBI, Stroke and Alzheimer’s Disease
5. The Alzheimer’s Epidemic Is Coming. How Can The National Association of Professional Geriatric Care Managers Help Prepare Families?
6. WOW Memories Announces New Efforts to Help Support Alzheimer’s Charity Events
7. Minocycline Enhances the Efficacy of Perispinal Enbrel in Traumatic Brain Injury Treatment as well as Stroke Treatment and Alzheimer’s Treatment
8. Breakthrough Drug MW151 Emerges as a Potential Competitor to Perispinally Administered Etanercept Inducing Rapid Recovery of Functions Lost to Alzheimer’s, Stroke and TBI
9. New Study from AAN: Herpes May Lead to Alzheimer’s Disease; polyDNA Recommends Gene-Eden-VIR Against the Herpes Virus
10. Living Well Assisted Living at Home Hosts Ongoing Support Group for Patients with Early Onset Alzheimer’s
11. New Study Links Air Pollution to Alzheimer’s Disease -- Says Cure Alzheimer's Fund
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... York (PRWEB) September 23, 2014 Eight-week program, ... cystitis, pudendal neuralgia, and other chronic pelvic or sexual pain, ... relief. , According to the Gallup poll, 1 in 7 ... chronic pelvic pain. Many of those women suffer in ... healthcare providers. The type of pain varies from woman ...
(Date:9/23/2014)... 23, 2014 People across Minnesota acknowledge ... healthy choices, but barriers are more prominent in the ... The Center for Prevention at Blue Cross and Blue ... access to healthy, affordable food and a lack of ... easily. About 60 percent of rural Minnesotans who responded ...
(Date:9/23/2014)... 23, 2014). Researchers from the University of ... Krischek, investigated gene expression in normal vestibular nerves ... made: 1) there is negligible difference between VSs ... neurofibromatosis Type 2 (NF2), a genetic disorder; and ... tumors may be an excellent therapeutic target. Detailed ...
(Date:9/23/2014)... 2014 "Bee Towers” was featured on NewsWatch ... features the latest technology gadgets and services available to consumers. ... the tech review and shared with viewers how ... , Tablet sales rates in the United States continue to ... now own a tablet. , For consumers who own ...
(Date:9/23/2014)... September 23, 2014 Steven Winter Associates, ... firm’s recent projects in the State of Connecticut – ... Gateway at 570 – were honored by the Connecticut ... Awards held on September 18, 2014 at Stepping Stones ... High School, Bridgeport , Recipient of the Institutional Award ...
Breaking Medicine News(10 mins):Health News:Mind Body Expert Launches Pelvic Pain Relief Program 2Health News:Minnesota Health Poll: One State, Different Challenges, Unique Solutions 2Health News:Minnesota Health Poll: One State, Different Challenges, Unique Solutions 3Health News:Minnesota Health Poll: One State, Different Challenges, Unique Solutions 4Health News:Minnesota Health Poll: One State, Different Challenges, Unique Solutions 5Health News:Aberrant PI3K/AKT/mTOR pathway found in vestibular schwanommas may be therapeutic target 2Health News:Aberrant PI3K/AKT/mTOR pathway found in vestibular schwanommas may be therapeutic target 3Health News:“Bee Towers”, a Floor Standing Tablet Holder by XAR Motion, was Featured on NewsWatch, a National Television Show, This Month 2Health News:Steven Winter Associates’ Projects Receive 2014 Green Building Awards 2Health News:Steven Winter Associates’ Projects Receive 2014 Green Building Awards 3
... RE: American Psychological Association 116th Annual Convention in Boston, ... Meeting Level 1, Boston Convention and Exhibition Center. ... and two high-speed printers. We will also provide working ... and APA staff resources. This room will also be ...
... -- Are the health needs of women adequately addressed ... the May issue of Mayo Clinic Proceedings, a team ... question. , The traditional model of medical research was ... results of research on white male participants could be ...
... Spa This Summer, FONTANA, Wis., May 12 ... - June, 2008, is the latest enhancement to The ... of Lake Geneva, Wisconsin., The newly renamed AVANI ... evokes feelings of tranquility, peace, relaxation, and rebirth.,Utilizing inspiration ...
... student, teachers, EMT among winners with inspirational, ... educational ... Foundation of,America, in partnership with Procter & Gamble Pharmaceuticals (P&G), has,selected ... to honor, educate and inspire those affected by ulcerative,colitis. Winners, stories ...
... May 12 FutureScripts(R), the premier,pharmacy benefit manager ... http://www.futurescripts.com . The website is a valuable tool ... to find key,information about the drugs on FutureScripts, ... "The new website allows our customers to ...
... , Montreal, May 12, 2008 Losing a limb can ... physical pain can linger for years. To better understand the ... Emma Duerden is inviting amputees to come forward and share ... is to better understand why amputees retain the memory of ...
Cached Medicine News:Health News:Highlights for APA's 116th Annual Convention in Boston, Aug. 14-17 2Health News:Highlights for APA's 116th Annual Convention in Boston, Aug. 14-17 3Health News:Highlights for APA's 116th Annual Convention in Boston, Aug. 14-17 4Health News:Medical research should include more women participants and examine the role of gender in disease 2Health News:Medical research should include more women participants and examine the role of gender in disease 3Health News:The AVANI Spa Debuts at the Abbey Resort 2Health News:The AVANI Spa Debuts at the Abbey Resort 3Health News:UPDATE: Celebrating UC Success Announces Essay Contest Winners 2Health News:UPDATE: Celebrating UC Success Announces Essay Contest Winners 3Health News:UPDATE: Celebrating UC Success Announces Essay Contest Winners 4Health News:UPDATE: Celebrating UC Success Announces Essay Contest Winners 5Health News:UPDATE: Celebrating UC Success Announces Essay Contest Winners 6Health News:Pharmacy Benefit Manager FutureScripts(R) Launches New Website 2Health News:Pharmacy Benefit Manager FutureScripts(R) Launches New Website 3
(Date:9/23/2014)... 2014  Savant HWP, Inc., a privately held ... human safety testing of 18-MC, an experimental treatment ... of 18-MC, administered as part of a double-blind, ... American partner, was well tolerated by healthy volunteers ... develop 18-MC as a treatment for many forms ...
(Date:9/23/2014)... , Sept. 23, 2014   BioLife Solutions , ... manufacturer and marketer of proprietary clinical grade hypothermic ... precision thermal shipping products for cells and ... additions to its Scientific Advisory Board.  The new members ... Davies , PhD. Dr. Acker is a ...
(Date:9/22/2014)... September 23, 2014 , ... authorities, increasing rigor for trial master file (TMF) accessibility ... largest TMF survey to date reveals an increase in ... provide auditors with remote access to their electronic trial ... surveyed in the Veeva 2014 Paperless TMF ...
Breaking Medicine Technology:Savant HWP Confirms Initiation of a Human Safety Trial for 18-MC, a Potential Anti-Addiction Therapy 2Savant HWP Confirms Initiation of a Human Safety Trial for 18-MC, a Potential Anti-Addiction Therapy 3BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 2BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 3BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 4BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 5BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 6BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 7Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 2Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 3Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 4
... Va., Oct. 8 Mirixa Corporation, the leader ... hiring of Cheryl Hoffer as Vice President, Pharmacy ... Pharmacy Account Management team, supporting independent and chain ... The Pharmacy Account Management team also helps expand ...
... LAKE FOREST, Ill., Oct. 8 Hospira, Inc. (NYSE: ... pharmaceuticals, today signed a Business Cooperation Agreement with South ... outlines the business terms of a future distribution agreement ... Canada for eight biogeneric products that are currently under ...
Cached Medicine Technology:Mirixa Corporation Announces Key Pharmacy Network Hire 2Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs 2Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs 3
... Farnsworth Dichotomous testing sets are designed ... The Farnsworth D15 test is used to ... Normal. The L'Anthony Desaturated test is much ... mild deficiency from Normal. Both of ...
... test is as easy as 1-2-3: just three ... patient satisfaction with rapid information before they leave ... immediately with the appropriate therapy; no more follow-up ... NOW® Strep A Test is a rapid immunochromatographic ...
12 mm single use, reloadable laparoscopic linear stapler with titanium staples....
Single Use Loading Units with Titanium Staples for use with Powered MULTIFIRE ENDO GIA™ 60 (15 mm Single Use Stapler with Titanium Staples)....
Medicine Products: